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Cone photoreceptors in the retina enable vision over a wide
range of light intensities. However, the processes enabling cone
vision in bright light (i.e. photopic vision) are not adequately
understood. Chromophore regeneration of cone photopig-
mentsmay require the retinal pigment epithelium (RPE) and/or
retinalMüller glia. In the RPE, isomerization of all-trans-retinyl
esters to 11-cis-retinol is mediated by the retinoid isomerohy-
drolase Rpe65. A putative alternative retinoid isomerase, dihy-
droceramide desaturase-1 (DES1), is expressed in RPE andMül-
ler cells. The retinol-isomerase activities of Rpe65 and Des1 are
inhibited by emixustat and fenretinide, respectively. Here, we
tested the effects of these visual cycle inhibitors on immediate,
early, and late phases of conephotopic vision. In zebrafish larvae
raised under cyclic light conditions, fenretinide impaired late
cone photopic vision, while the emixustat-treated zebrafish
unexpectedly had normal vision. In contrast, emixustat-treated
larvae raised under extensive dark-adaptation displayed signif-
icantly attenuated immediate photopic vision concomitant with
significantly reduced 11-cis-retinaldehyde (11cRAL). Following
30 min of light, early photopic vision was recovered, despite
11cRAL levels remaining significantly reduced. Defects in
immediate cone photopic vision were rescued in emixustat- or
fenretinide-treated larvae following exogenous 9-cis-retinalde-
hyde supplementation. Genetic knockout of Des1 (degs1) or
retinaldehyde-binding protein 1b (rlbp1b) did not eliminate
photopic vision in zebrafish. Our findings define molecular and
temporal requirements of the nonphotopic or photopic visual
cycles for mediating vision in bright light.
Photopic vision is the physiological function mediating
vision in well-lit conditions. Daytime vision requires cone pho-
toreceptors to remain functional in the presence of light. This
capability requires regeneration of cone photopigments in the
retina prior to and during light onset. However, our under-
standing of the biological process contributing to immediate,
early, and late phases of cone photopic vision is inadequate.
Sustained vision in vertebrates dependsupon a supply of 11-cis-
retinaldehyde (11cRAL)3 chromophore to regenerate photo-
bleached visual pigments. The canonical visual cycle is the enzy-
matic pathway in the retinal pigment epithelium (RPE) that
recycles visual chromophore (1). The retinoid isomerase in RPE
cells is RPE65, which converts all-trans retinyl esters (atREs), syn-
thesized by lecithin–retinol acyltransferase, to 11-cis-retinol
(11cROL) (2–4). Null mutations in themouse Rpe65 or Lrat gene
cause the virtual absence of 11cRALwithin the neural retina (5, 6).
Rpe65/mice exhibitmassive accumulation of atREs in theRPE,
whereas retinoids are almost undetectable in the RPE of Lrat/
mice (7, 8).Notably, there is still uncertainty as to if, andwhen, the
RPE65 visual cycle contributes to cone photopic vision.
Under daylight conditions, the estimated rate of 11cRAL
synthesis by RPE cells is much slower than the rate of chro-
mophore consumption by rods and cones (9). Despite the non-
contribution of rods to daylight vision, rhodopsin continues to
photoisomerize in bright light exposed retinas. Cones must
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the highest. As a possible adaptation, cones can regenerate cone
opsin pigments by uptake of either 11cRAL or 11cROL,
although rods can only uptake 11cRAL (10–12). Müller glial
cells of the neural retina are the likely source of this 11cROL
(13). Dihydroceramide desaturase (DES1; encoded by DEGS1)
andmultifunctionalO-acyltransferase (MFAT) represent another
retinol isomerase—retinyl-ester synthase pair, present in Müller
cells, which may mediate 11cROL synthesis. The “isomerosyn-
thase” activity of DES1—MFAT is present in retinas from cone-
dominant chickens and ground squirrels but is undetectable in
retinas from rod-dominant mice and cattle (9, 14). This
activity correlated with the presence of 11-cis-retinyl esters
(11cREs) in the neural retina, which are undetectable in
mice and cattle retinas. Interestingly, synthesis of 11cROL
by DES1 is increased through interactions with cellular
retinaldehyde–bindingprotein (CRALBP; encodedbyRLBP1), an
11cRAL/11cROL carrier protein expressed in the RPE and
Müller glia (15).
In contrast to the evidence supporting a role for DES1 in cone
chromophore regeneration, a recent study reported that recovery
of cone electrophysiological sensitivity, in isolated retinas follow-
ing a photobleach, was similar in Des1/ and Müller cell condi-
tionalDes1/mutantmice (16).This suggestsMüllerDES1plays
no role in the generation of retinoids to recover mouse cone elec-
troretinograms. However, uncertainty remains regarding the
overall contribution of DES1 to the cone visual cycle as significant
DES1 activity remained in retinal lysates of these Müller cell
Des1/mice. Additionally, the cone electrophysiological studies
were conducted in rod-dominantmice, whereasDES1was identi-
fied in Müller cells from cone-dominant chicken. Thus, uncer-
tainly remains whether species specific retinoid isomerase path-
ways exist to meet cone chromophore demands.
Another mechanism postulated to replenish cones with chro-
mophore is the photopic visual cycle, a process that regenerates
11cRAL by a light-dependent mechanism. The nonvisual opsin,
retinal G-protein–coupled receptor (RGR) opsin, is present in
RPEandMüller cells. Previous reports showRGR-opsin is integral
to light-dependent biochemical formation of 11cRAL that recon-
stitutes rhodopsin visual pigment in rods (17). RGR-opsin appears
essential for the recoveryof coneelectrophysiological sensitivity as
retinas fromWTmice under sustained background illumination
maintained cone sensitivity, whereas Rgr/ mice exhibited
diminishing cone sensitivity during light exposure (18). Nota-
bly, all these studies assess cone electroretinography (ERG)
and not cone vision. It is well-recognized that electrophysi-
ology does not absolutely correlate to functional vision. For
example, patients receiving gene therapy for RPE65 defects
show no improvement in ERG but show significant
improved ability to navigate an obstacle course (19).
Most visual cycle knowledge was ascertained by studying the
retinae of rod-dominant mice. Consequently, investigations
of the visual cycles enabling cone vision are less advanced.
Zebrafish larvae provide novel opportunities to study cone pho-
topic vision and the supporting visual cycle processes (20) due to
easy genetic and pharmacological manipulation and cone-domi-
nant vision until 15 dpf, the stage when rods become functional
(21, 22). Previous studies investigating visual cycle components in
zebrafish relied on transient morpholino knockdown. Zebrafish
rpe65a knockdown significantly reduced but did not completely
attenuate 11cRAL synthesis, supporting the presence of an alter-
native pathway for chromophore synthesis in zebrafish retinae
(20). Knockdown of either Cralbpa or Cralbpb in zebrafish
resulted in reduced visual behavior (23) and reduced light sensitiv-
ity (24).
Pharmacological modulators that inhibit or complement the
visual cycles are potential treatments for retinal disease (25, 26).
Following photoisomerization, released atRAL must be deliv-
ered to RPE/Müller cells to regenerate 11cRAL to restore light
sensitivity. Impaired atRAL clearance from photoreceptors
leads to accumulation of bis-retinoid N-retinylidene–N-
retinylethanolamine, a toxic by-product of atRAL and a patho-
logical hallmark of age-related macular degeneration and Star-
gardt’s disease (27). Emixustat (ACU-4429) competitively
inhibits Rpe65 and hinders retinaldehyde-mediated destruc-
tion of photoreceptors by acting as a retinaldehyde scavenger
(26). Inhibition of chromophore synthesis gives rise to unligan-
ded “noisy” opsins that stimulate the transduction pathway in
the absence of light, greatly decreasing photoreceptor sensitiv-
ity (28). In Rpe65/ mice, chronic activation of signal trans-
ductionmay cause photoreceptor degeneration (29). Free opsin
can be targeted by chromophore replacement therapy with
9cRAL, which bypasses the visual cycle defect to form isorho-
dopsin or iso-cone opsins. Following 9cRAL treatment, light
sensitivity is restored long-term in Rpe65/ mice with atten-
uated accumulation of atREs (30). Fenretinide, a derivative of
retinoic acid, is reported to inhibit DES1 without affecting
RPE65 activity (31–33). Fenretinide also competes with retinol
for binding to retinol-binding protein (RBP4) in blood, causing
a mild vitamin A deficiency (34). A1120 is a nonretinoid RBP4
antagonist, which in mice reduces serum retinol levels in a
dose-dependent manner (35) and reduces lipofuscin accumu-
lation in Abca4/mice through reduction of serumRBP4 and
visual retinoids (34). Unlike fenretinide, A1120 does not act as a
retinoic acid receptor  agonist. A1120 does not affect RPE65
isomerohydrolase activity in ex vivo experiments (34).
Previous visual cycle inhibition studies focused onmeasuring
retinal function (e.g. electrophysiology) as the primary end
point. Reduced cone photosensitivity was observed in livemice,
ex vivo mouse retinae, and in ground squirrels treated with
visual cycle inhibitors (32). To our knowledge, no previous
studies investigated the relationship between visual cycle mod-
ulation and cone photopic visual behavior. In this study, we
used visual behavior assays, visual cycle inhibitors, and genetic
approaches in zebrafish to understand the mechanisms regu-
lating immediate (at light onset following dark adaptation, 0
min), early (after 30min light adaptation), or late (after4–6 h
light adaptation) phases of cone photopic vision.Original findings
were uncovered in relation to cone photopic vision, including: (i)
latephotopicvision is significantly impairedby fenretinide,butnot
by emixustat; (ii) immediate photopic vision is reliant on Rpe65;
(iii) 30min of light is sufficient to restore early photopic vision and
surmount the RPE65 inhibitor emixustat; (iv) the RPE65-inde-
pendent recovery of early photopic visionoccurswith low levels of
11cRAL; (v) exogenous 9cRAL is sufficient to restore photopic
vision; and (vi) photopic visionwas not eliminated upon knockout
of degs1 or RPE-expressed rlbp1b.
Chemical biology of visual cycles enabling cone vision
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Results
Fenretinide, but not emixustat, impairs late cone photopic
vision in zebrafish larvae
To investigate the effects of visual cycle inhibitors on cone
vision, we assayed the effects of pharmacological agents, previ-
ously used in human clinical trials (36, 37), on the vision of 5 dpf
zebrafish larvae. Previous studies demonstrate 5 dpf zebrafish rely
exclusively on cones for vision (38). Emixustat is a potent RPE65
inhibitor, whereas targets of fenretinide include DES1 (the puta-
tive isomerase II) (32) and retinol-binding protein 4 (Rbp4) in
blood (34).Larvaewere raisedundernormalcyclic lightconditions
(14 h light and 10 h dark) for the duration of the experiment and
treatedwith emixustat or fenretinide from3dpf.Drugwas replen-
ished at 4 dpf, and OKR analysis was completed at 5 dpf between
ZT 2.5 and ZT 6.5 (Fig. 1A). OKR parameters used for all experi-
ments were 20 alternating black and white stripes (18° per stripe,
99% contrast) rotated at 18 rpm. Surprisingly, late photopic vision
was unaffected in 5 dpf larvae treated with up to 50 M emixustat
(24.3 4.9 saccades per min) (Fig. 1B). In contrast, larvae treated
with 10 M fenretinide displayed significantly fewer (p  0.001)
saccadespermin(7.75), comparedwithvehiclecontrols (24.2
8.2) (Fig. 1B).Whole-mount images reveal that 5dpf larvae treated
with emixustat or fenretinide fail to inflate their swimbladder, but
otherwisehavenormal grossmorphology (Fig. 1C). Fig. 1Ddepicts
potential targets of emixustat and fenretinide in zebrafish.
Zebrafishhave three rpe65 isoforms, twoofwhichare expressed in
the eye (20, 39). Emixustat may inhibit RPE-expressed rpe65a or
Müller-cell expressed rpe65c (Fig. 1D). Fenretinide may inhibit
Des1 isomerase activity in Müller cells/RPE or inhibit uptake of
atROL from the serum by blocking Rbp4–transthyretin interac-
tions. In summary, in cyclic lighting conditions, a broad-spectrum
visual cycle inhibitor impairs late photopic vision,whereas a selec-
tive inhibitor of the canonical visual cycle did not affect vision.
In dark-adapted zebrafish, emixustat blocks immediate
photopic vision and fenretinide exerts an additive effect
As Rpe65 is important for chromophore regeneration under
dark conditions, we tested the visual cycle inhibitors in dark-
Figure1.Fenretinide,butnotemixustat, impairs lateconephotopicvisioninzebrafish larvae.A,schematic representation of experimental workflow. Zebrafish
larvae were treated initially at 3 dpf, and the drug was replaced at 4 dpf. Larvae were incubated under standard lighting conditions (14 h light and 10 h dark) until OKR
analysis at 5 dpf. B, OKR in 5 dpf larvae following treatment with 50 M emixustat and 10 M fenretinide. Data were analyzed by one-way ANOVA and Dunnett’s
multiple comparisons post hoc test, wherensnot significant (p0.05) and ***p0.001.n30 larvae with three independent biological replicates.C,dorsal and
lateral bright-field microscopy images of larvae following treatment with 50 M emixustat or 10 M fenretinide at 5 dpf. Scale bar 2 mm. D, schematic overview
mapping all possible mechanisms of cone chromophore regeneration in zebrafish, including the confirmed molecular targets of both emixustat and fenretinide.
Proteins colored in blue depict fenretinide targets (Rbp4, Lrata, and Des1), and those in green highlight (potential) targets of emixustat (Rpe65a and Rpe65c) in
zebrafish.
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adapted zebrafish larvae wherein larvae were raised under nor-
mal cyclic light conditions until 3–4 dpf, then treatedwith drug
under constant dark conditions until 5 dpf. Dose-response and
dose-frequency studies revealed that 50 M emixustat added at
day 3 and replaced at day 4 caused the most significant reduc-
tion in OKR saccade numbers/min (7.1 4.6, p 0.001) com-
pared with vehicle controls (20.9  5) (Fig. 2A). Larvae were
then treated with a combination of emixustat and fenretinide.
Drug(s) were added at 3 dpf and replaced at 4 dpf, and visual
behavior analysis was performed between ZT 2.5 and ZT 6.5 on
5 dpf, wherein the larvae were individually removed from wells
and immediately subjected to OKR following a 2-day dark
adaptation (Fig. 2B). Under dark conditions, larvae treated with
10 M fenretinide displayed an6-fold reduction in the ability
to track 1 cm thick rotating stripes, whereas larvae treated with
50 M emixustat had an 2.5-fold decrease in OKR. Interest-
ingly, when both isomerase inhibitors were combined, imme-
diate photopic vision was completely abolished (1.2 saccades/
min, p  0.001) and reduced by 22-fold, compared with
vehicle controls (26.8 saccades per min) (Fig. 2C). Larvae
treated with emixustat and fenretinide in the dark were mor-
phologically normal, other than they did not inflate their swim
bladder (Fig. 2D) as also observed under a normal light/dark
cycle (Fig. 1C). An uninflated swim bladder is commonly
observed in visually-compromised zebrafish larvae (40, 41).
Interestingly, neither 50 M emixustat nor 10 M fenretinide
Figure 2. In dark-adapted zebrafish, emixustat blocks immediate photopic vision and fenretinide exerts an additive effect. A, optimization of dose and
treatment time points for emixustat. Larval OKR at 5 dpf following treatment with 10, 20, or 50 M emixustat at 3, 4, and 3 and 4 dpf. Data were analyzed by two-way
ANOVA and Bonferroni post hoc test, where *p0.05, **p0.01, and ***p0.001.n30 larvae with three independent biological replicates.B, schematic
representation of experimental workflow. Zebrafish larvae were initially treated with emixustat and/or fenretinide at 3 dpf, and drug(s) were replaced at 4 dpf. Larvae
were incubated under dark conditions until OKR analysis at 5 dpf. C, larval OKR at 5 dpf following combination treatment with 50 M emixustat and/or 10 M
fenretinide at days 3 and 4. Data were analyzed by two-way ANOVA and Bonferroni post hoc test, where ns not significant and ** p 0.01.D, dorsal and lateral
bright-field microscopy images of larvae at 5 dpf following treatment with 50 M emixustat and/or 10 M fenretinide.Scalebar2 mm.E, retinal morphology of 5 dpf
larvae treated with 0.5% DMSO, 50 M emixustat, or 10 M fenretinide. Retinal bright-field images taken with a	60 and	100 objective.PRL,photoreceptor layer;OPL,
outer plexiform layer;ONL,outer nuclear layer; IPL, inner plexiform layer; INL, inner nuclear layer.Scalebar50 and 20 m, respectively.E
–G
, high-resolution images
of photoreceptor outer segments (OS, yellowdotted line) and RPE in 5 dpf larvae. Scale bar 5 m. E–G, immunohistochemistry on transverse section across lens at
5 dpf. Double cones were stained with zpr-1 antibody. Scale bar 20 m.
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induced obvious changes in retinal histology, particularly the
photoreceptor outer segment structure and RPE, compared
with vehicle controls (Fig. 2, E–G and E
–G
). Furthermore,
double cones stained with zpr-1 appear unaffected by fen-
retinide or emixustat treatment (Fig. 2,E–G). Thus, emixustat
impaired immediate photopic vision following dark adaptation
(Fig. 2, A and C) but not late photopic vision (Fig. 1B), whereas
fenretinide inhibited both immediate and late photopic vision.
Visual cycle inhibitors modulate the profile of key retinoids in
zebrafish
To assess the pharmacological specificity of the phenotypes
in zebrafish, we measured the content of visual retinoids in
zebrafish larval heads following pharmacological visual cycle
inhibition. Animals genetically or pharmacologically devoid of
functional visual cycles can present with significantly-altered
levels of retinoids in the eye and liver (3, 20, 24, 26, 42, 43). In
agreement with the impaired immediate photopic vision we
observe in zebrafish, we observed a significant reduction in
11cRAL, 11cROL, and the 11cRE, 11-cis-retinyl palmitate
(11cRP), following emixustat and fenretinide treatment, alone
or in combination (p 0.001) (Fig. 3B). Rpe65 uses atREs as its
substrate; therefore, elevated levels could be expected in the
presence of emixustat (2). Interestingly, atROL (23.2  3.8
pmol/mg, p  0.01) was significantly reduced in fenretinide-
only treated larvae compared with the vehicle control (70.5
27.3). These data suggest that emixustat and fenretinide
impair immediate photopic vision following dark adaptation
in zebrafish by reducing 11cRAL levels.
Supplementation with exogenous 9cRAL significantly
improves immediate photopic vision in emixustat- and
fenretinide-treated larvae
As cone function is partially restored in Rpe65/ mice fol-
lowing treatmentwith 9cRAL, a functional analogue of 11cRAL
Figure3.Visual cycle inhibitorsmodulate theprofileof key retinoids in zebrafish.A, schematic representation of experimental workflow. Zebrafish larvae
were initially treated with 50 M emixustat and/or 10 M fenretinide at 3 dpf, and the drug was replaced at 4 dpf. Larvae were incubated under dark conditions
until the collection of larval heads for retinoid analysis at 5 dpf. B, retinoid profiles of 5 dpf larvae treated with emixustat and fenretinide, alone and in
combination. Bars represent the mean S.D. of three independent experiments for each condition with 105 larval heads per biological replicate. Data were
analyzed by a one-way ANOVA and Dunnett’s multiple comparisons post hoc test, where * p 0.05, ** p 0.01, and *** p 0.001.
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(44), we measured cone vision following treatment with exog-
enous 9cRAL. Larvae were treated with emixustat and/or fen-
retinide under dark-adapted conditions as described above
(Fig. 2B). In addition, larvae were treated with 9cRAL 4 h fol-
lowing treatment with emixustat and/or fenretinide at both 3
and 4 dpf (Fig. 4A). Immediate photopic vision in emixustat-
treated larvae supplemented with 9cRAL improved signifi-
cantly (16.1 6.7 saccades per min, p 0.001), compared with
emixustat treatment alone (10.5  4.8 saccades per min) (Fig.
4B).We also observed2-fold (6.5 5.5 saccades permin, p
0.01) improved cone vision in fenretinide-treated larvae fol-
lowing supplementation with 9cRAL (Fig. 4B). Addition of
exogenous 9cRAL also improved vision in emixustat- plus
fenretinide-treated larvae 5-fold compared with emixus-
tat- and fenretinide-treated larvae without 9cRAL supple-
mentation (5.3 versus 4.2 saccades per min, respectively)
(Fig. 4B). No gross morphological changes were observed in
larvae treated with 9cRAL in combination with either drug
alone or in addition to fenretinide plus emixustat (Fig. 4C).
Interestingly, larvae treated with emixustat and 9cRAL
inflated their swim bladders (Fig. 4C), a characteristic not
observed in larvae treated with emixustat alone (Fig. 2D).
Finally, treatment of larvae with exogenous 9cRAL altered
retinoid profiles at 5 dpf (Fig. 4D and Fig. S1). All 9-cis-
retinoids (9cRP, 9cROL, and 9cRAL) and atRP significantly
increased in emixustat plus 9cRAL-treated larvae, compared
with emixustat alone. Interestingly, no significant increase
was observed in 11cRAL profile following 9cRAL supple-
mentation. Thus, the reduction in immediate photopic
vision in emixustat- and fenretinide-treated larvae results
not from toxic effects but rather from visual cycle inhibition.
Early photopic vision recovers in emixustat-treated larvae
following exposure to light
Recent studies proposed the noncanonical visual cycle depends
onanRpe65-independent isomerization event that relies onRGR-
opsin and occurs during sustained exposure to visible light (18).
We hypothesized that exposure of larvae to light for 30 min fol-
lowing a prolonged dark adaptation may activate the alternative
pathway and modulate the impaired visual behavior in larvae
treatedwith emixustat and fenretinide under dark-adapted condi-
tions (Fig. 2C). At 5 dpf, between ZT 2.5 and ZT 6.5, larvae were
subjected toour standardOKRassay immediately after dark adap-
tation for 2 days (0 min) or following 30 min of subsequent expo-
sure to ambient light (Fig. 5A). Pre-treatment with 50M emixus-
tat partially suppressed immediate photopic vision in dark-
adapted larvae (11.4 7.6 saccades permin, p 0.001) compared
with vehicle controls (17.3 saccades permin) (Fig. 5B). In contrast,
pre-treatment with 10M fenretinide virtually abolished immedi-
ate cone photopic vision in dark-adapted larvae (1.7 3 saccades
per min, p 0.0.001) compared with the vehicle control (17.3
4.5 saccades permin) (Fig. 5B). To help discriminate whether fen-
retinideacts viaRbp4orDes1,A1120, apotentRbp4 inhibitor,was
tested. Similar to fenretinide, A1120 suppressed immediate cone
photopic vision (10.2 6.6 saccades per min). Subsequent expo-
sureofuntreated larvae to30minof lighthadaminimumeffecton
early cone visual function versus untreated, dark-adapted larvae
(Fig. 5B).
Interestingly, early photopic vision in emixustat-treated larvae
was indistinguishable from vehicle-only treated larvae after a
30-min exposure to light (Fig. 5B), despite lower 11cRAL levels in
larvae treated with emixustat (Fig. 5C). Pre-treatment of larvae
with fenretinidevirtually abolishedconevision following30minof
light exposure, similar to fenretinide-treated, dark-adapted larvae
(Fig. 5B). Surprisingly, early photopic vision in A1120-treated lar-
vae recovered to vehicle control levels (21 5 saccades per min)
indicating that the block in early photopic vision observed follow-
ing fenretinide treatment is not a result of inhibiting Rbp4 (Fig.
5B).
The relatively normal cone OKRs in emixustat-treated lar-
vae following light exposure raised the question whether this
correlated with increased 11cRAL chromophore levels. Reti-
noid levels were profiled in emixustat-treated larval heads at 0
and 30 min of light exposure (Fig. 5C). Although vision recov-
ered following 30 min of light exposure (Fig. 5B), 11cRAL
levels surprisingly did not change. Interestingly, atRAL levels
returned to that of the vehicle control following 30 min of light
indicating photoisomerization of light-sensitive chromophore
and activation of the phototransduction cascade.
As early photopic vision, in the presence of emixustat, recov-
ered following exposure to ambient light for 30min, there was a
possibility of light-induced degradation or inactivation of emix-
ustat. To test this possibility, we performed MS analysis of
emixustat before and after light exposure. No change in the
relative abundance of the ion corresponding to emixustat
(m/z 263.81—264.26) was observed (Fig. 5D). NMR analysis
also demonstrated no chemical change to emixustat upon
exposure to visible light (Fig. 5E).
To confirm that early photopic vision was not mediated by
reactivation of RPE65, larvae were treated in the dark with
emixustat from 3 dpf, and emixustat was removed at 5 dpf
under dim red light, 30min beforeOKRanalysis at ZT2.5 toZT
6.5. OKR was conducted at 0- and 30-min post light exposure
(Fig. 6A). As before, emixustat-treated larvae presented with
significantly reduced immediate photopic vision following dark
adaptation (13.8  6.1 saccades per min, p  0.0003), which
recovered 30 min post light exposure (23.4  6.5, p  0.0001)
(Fig. 6B). Retinoid analysis revealed a reduction in 11cRAL,
which did not recover following a 30-min absence of emixustat
and/or 30min of light exposure (Fig. 6C). A significant increase
in atRP in emixustat-treated larvae in both the 0- and 30-min
groups reaffirms Rpe65 inhibition (Fig. 6C). In summary,
although emixustat-treatedWT larvae display impaired imme-
diate photopic vision, larvae can regain vision following 30 min
of light exposure. This light-dependent recovery of early pho-
topic vision is not due to Rpe65 isomerase activity.
Des1 knockout does not eliminate cone photopic vision in
zebrafish at 5 dpf
Controversially, previous studies implicated DES1 as the
isomerase II in regeneration of cone visual pigments through
the intraretinal visual cycle (15). To test whether Des1 is an
important modulator of cone photopic vision, we created
degs1/ zebrafish using CRISPR/Cas9 by engineering a
484-bp deletion in exon 2 (Fig. 7A). Expression of degs1 was
analyzed with primers that span the deletion (primer set 2) or
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Figure4. Supplementationwith exogenous9cRAL significantly improves immediatephotopic vision in emixustat- and fenretinide-treated larvae.A,
schematic representation of experimental workflow. Zebrafish larvae were treated initially at 3 dpf, and the drug was replaced at 4 dpf. 9cRAL was added to the
medium 4 h following 50 M emixustat and/or 10 M fenretinide treatment on both 3 and 4 dpf. Larvae were incubated in the dark until OKR analysis at 5 dpf.
B, larval OKR following addition of 10 M 9cRAL to larvae previously treated with 50 M emixustat and 10 M fenretinide, alone or in combination at 3 and 4 dpf.
Data were analyzed by unpaired, two-tailed t tests, where *  p  0.05, **  p  0.01, and ***  p  0.001. ns  not significant. n  30 larvae with three
independent biological replicates. C, dorsal and lateral bright-field microscopy images of larvae at 5 dpf larvae treated with 50 M emixustat and/or 10 M
fenretinide in combination with 10 M 9cRAL. Scale bar  2 mm. D, retinoid profiles following exogenous 9cRAL supplementation in vehicle control and
emixustat-treated zebrafish larvae. Bars represent the mean S.D. of three independent experiments for each condition with 105 larval heads per biological
replicate. Data were analyzed by unpaired, two-tailed t tests, where * p 0.05, ** p 0.01, and *** p 0.001. ns not significant.
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are nested within the deleted site (primer set 3) (Fig. 7A).
Primer set 2 amplified a lower band of 61 bp indicating the
presence of the transcript with deletion; however, it did not
amplify the upper (537 bp) product observed in WT and
degs1/ samples (Fig. 7B). Moreover, when primer set 3 was
used, a 162-bp product is seen in WT and degs1/ lanes,
althoughnoproductwas amplified fromdegs1/ samples (Fig.
7B). No gross morphological differences were observed in
degs1/ larvae at 5 dpf, compared with their unaffected sib-
lings (Fig. 7C). Late photopic vision at ZT 2.5–6.5 is not signif-
Figure 5. Early photopic vision recovers in emixustat-treated larvae following exposure to light. A, schematic representation of experimental
workflow. Zebrafish larvae were treated initially at 3 dpf, and drug was replaced at 4 dpf. Larvae were incubated under dark conditions until analysis at
5 dpf. At 5 dpf, larvae were subjected to OKR immediately following dark adaptation (0 min) or following 30 min of light (30 min). B, OKR of 5 dpf larvae
treated with 50 M emixustat, 50 M A1120, or 10 M fenretinide 0 and 30 min following light exposure. Data were analyzed by unpaired, two-tailed t
tests, where ns not significant; *** p 0.001. n 30 larvae with three independent biological replicates. C, retinoid profiles of 5 dpf larvae treated
with 50 M emixustat following no light exposure (0 min) or 30 min of light exposure (30 min). Bars represent the mean  S.D. of three independent
experiments for each condition with 105 larval heads per biological replicate. Data were analyzed by unpaired, two-tailed t tests, where ns  not
significant and *** p 0.001. D, emixustat-extracted ion chromatograms (at m/z 264, RT 7.1 min) and high-resolution mass spectrum (m/z 264.1976
[M  H]) highlighting no change in the MS profile of emixustat exposed to 30 min of light and samples that received no light (0 min). E, NMR light
sensitivity analysis of emixustat. Emixustat was dissolved in DMSO-d6 (600 l) covered with aluminum foil until
1H NMR and HSQC experiments were
performed (0 min). The NMR tube was left exposed to visible light for 30 min, followed by a second NMR analysis (30 min). Peaks at 2.09 and 5.76 ppm
correspond to acetone and dichloromethane, respectively.
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icantly affected indegs1/ larvae (18.5 5.4 saccades permin)
at 5 dpf compared with unaffected degs1/ or degs1/ sib-
lings (17.1  5.3 saccades per min) (Fig. 7, D and E). We ran-
domly drug-treated offspring from a degs1/ in cross with
50 M emixustat and incubated in the dark (Fig. 7F). Inter-
estingly, neither immediate nor early photopic vision is sig-
nificantly affected between the populations treated with
vehicle or 50 M emixustat (Fig. 7G). A genotyped sample of
each group validated the normal photopic response of
degs1/ larvae (Fig. 7H).
Knockout of RPE-expressed rlbp1b does not eliminate cone
photopic vision in zebrafish at 5 dpf
Co-immunoprecipitation experiments revealed that RLBP1-
encoded CRALBP interacts with DES1 and increases the rate
of 11cROL synthesis (15). Zebrafish rlbp1 has subfunction-
alized, with rlbp1a expressed in Müller cells and rlbp1b
expressed in the RPE (25, 26). Here, a zebrafish knockout
of RPE-expressed rlbp1b was created using CRISPR/Cas9,
which introduced a 1440-bp deletion across exons 2 and 3
(Fig. 8A). Following rlbp1b knockout, rlbp1b gene expres-
sion was completely abolished (p  0.0001) in rlbp1b/ F2
larval eyes (Fig. 8C). Gross morphology of rlbp1b/ larvae
is identical to their siblings at 5 dpf (Fig. 8D). Previous stud-
ies report a reduction in cone vision and function following
Rlbp1b knockdown (25, 26); here, however, no differences in
immediate (p 0.59), early (p 0.9), or late photopic vision
(p  0.24) were observed when tested under standard OKR
conditions (Fig. 8, E and F).
Discussion
Many daily tasks are dependent on the ability of the eye to
functionally adapt to changes in light. Vision inwell-lit environ-
ments is known as photopic vision and is mediated by cone
photoreceptors (45). Little is known regarding the biological
processes underpinning functional photopic vision. Here, we
apply chemical biology and genetics to dissect the contribution
of light, retinoids, retinoid carrier proteins, and retinoid iso-
Figure 6. In the absence of light, 30min alone is not sufficient to restore vision or 11cRAL levels. A, schematic representation of experimental workflow.
Zebrafish larvae were treated initially at 3 dpf, and drug was replaced at 4 dpf. Larvae were incubated under dark conditions until analysis at 5 dpf. At 5 dpf,
emixustat was removed under dim red light 30 min before larvae were subjected to OKR immediately following dark adaptation (0 min) or following 30 min
light adaptation (30 min). B, optokinetic response 30 min following removal of emixustat at 5 dpf larvae 0 and 30 min following light exposure. Data were
analyzed by unpaired, two-tailed t tests, where ns  not significant, **  p  0.01, and ***  p  0.001. n  30 larvae with three independent biological
replicates.C, retinoid profiles of 5 dpf larvae treated with 50 M emixustat. Emixustat was removed 30 min before dissection at 0- or 30-min post light exposure.
Bars represent the mean S.D. of three independent experiments for each condition with 105 larval heads per biological replicate. Data were analyzed by
unpaired, two-tailed t-tests, where ns not significant; ** p 0.01, and *** p 0.001.
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Figure7.Des1knockoutdoesnoteliminate conephotopicvision inzebrafishat5dpf.A,CRISPR/Cas9 knockout strategy ofdegs1 in zebrafish. Both guides
were targeted to exon 2 to induce a 484-bp deletion in the degs1 gene that contains three exons in total. Forward primer 1 (FP1) to reverse primer 1 (RP1)
amplifies an 807-bp genomic DNA WT product or a 323-bp product when deletion is present. For mRNA expression analysis, we used forward primer 2 (FP2) to
reverse primer 2 (RP2), which span the deletion and amplify a 537-bp WT product or 61 bp when the deletion is present. Forward primer 3 (FP3) to reverse
primer 3 (RP3) is nested within the deletion and amplifies a 162-bp WT product. B, agarose gel (1.5%) depicting degs1 expression in WT, degs1/ or degs/
zebrafish. L 100-bp ladder. Red box highlights the 61-bp product expected following a deletion event with primer set 2 in degs1/ or degs1/ samples. C,
dorsal and lateral bright-field microscopy images of untreated degs1 sibling (degs1/ or degs1/) and degs1/ larvae at 5 dpf. Scale bar  2 mm. D,
schematic representation of experimental workflow. degs1/ larvae were incubated under standard lighting conditions (14 h light and 10 h dark) until OKR
analysis at 5 dpf. E, OKR of degs1/ and sibling larvae at 5 dpf larvae following standard 14-h light and 10-h dark conditions. Data were analyzed by an
unpaired, two-tailed t test, where ns not significant (p 0.05). n 30 larvae with three independent biological replicates. F, schematic representation of
experimental workflow. Des1/ larvae were treated initially with 50 M emixustat at 3 dpf, and drug was replaced at 4 dpf. Larvae were incubated under dark
conditions until analysis at 5 dpf. G, at 5 dpf, a mixed population of degs1/ and unaffected sibling larvae were subjected to OKR immediately following dark
adaptation (0 min) or following 30 min of light (30 min). Red pointsdenote the larvae genotyped following OKR. Data were analyzed by an unpaired, two-tailed
t test, where ns not significant and *** p 0.001. n 64 larvae per group with two independent biological replicates. H, agarose gel (1.5%) highlighting
genotypes of high/low-responding larvae in OKR assay. White arrows denote degs1/ larvae. Eight larvae were genotyped per group (	4 “low responders”
and	4 “high responders”). L 100-bp ladder.
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Figure 8. Knockout of RPE-expressed rlbp1b does not eliminate cone photopic vision in zebrafish at 5 dpf. A, CRISPR/Cas9 knockout strategy of
RPE-expressed rlbp1b. Guides were targeted to exon 2 and exon 3 to induce a 1440-bp deletion in rlbp1b that contains seven exons. Forward primer 1 (FP1) to
reverse primer 1 (RP1) amplifies a 1688-bp WT product or a 248-bp product when deletion is present. A poison forward primer (FP2)was designed in the middle
of the deleted region to amplify a 469-bp WT product. B, agarose gel (1.5%) depicting the presence of the deletion in individual F2 larval genomic DNA. A WT
control was used to amplify the upper band (469 bp), and gDNA from the injected F0 parent fin was used as a positive control to amplify both upper and lower
bands (mosaic). L 100-bp ladder. C, gene expression analysis of rlbp1b in rlbp1b/ eyes. Data were analyzed by an unpaired, two-tailed t test, where ***
p 0.001. Three independent biological replicates were performed with at least 10 larvae per replicate.D, dorsal and lateral bright-field microscopy images of
untreated WT, rlbp1b/, and rlbp1b/ larvae at 5 dpf. Scale bar  2 mm. E, schematic representation of experimental workflow. Rlbp1b/ larvae were
incubated under standard lighting conditions (14 h light and 10 h dark) until OKR analysis at 5 dpf. F, late photopic vision was measured by OKR in 5 dpf larvae.
Data were analyzed by an unpaired, two-tailed t test, where ns  not significant (p  0.05). n  36 larvae with three independent biological replicates. G,
schematic representation of experimental workflow. Rlbp1b/ larvae were treated initially with 50 M emixustat at 3 dpf, and drug was replaced at 4 dpf.
Larvae were incubated under dark conditions until analysis at 5 dpf. H, at 5 dpf larvae were subjected to OKR immediately following dark adaptation (0min) or
following 30 min of light (30 min). Data were analyzed by an unpaired, two-tailed t test, wherensnot significant and ***p 0.001.n 36 larvae with three
independent biological replicates.
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merases to photopic vision (i) immediately following dark
adaptation, (ii) after 30 min of light, or (iii) after 4–6 h of
light. We exploited emixustat for its chemical ability to scav-
enge retinal and to inhibit the RPE65 isomerase (26). Likewise,
fenretinide causes depletion of vitamin A by disrupting the ret-
inol-dependent binding of RBP4 to transthyretin (35), and it
also inhibits the DES1 isomerase (31–33). A1120 is a more-
selective RBP4 antagonist.
Immediate and late cone photopic vision depend on different
visual cycle pathways
The ray-finned fish lineage, including zebrafish, underwent
whole-genome duplication resulting in two paralogues ofmany
teleost genes (46). In zebrafish, Rpe65a is exclusively expressed
in theRPE,whereas a contentiousRpe65c isoformwas localized
to retinal Müller glia (39). Based on this expression pattern and
the requirement of mammalian cones on both the RPE and
intraretinal visual cycles for complete dark adaptation (47), we
predicted that emixustat could impair both immediate and pos-
sibly also early/late cone-based vision. Although emixustat
inhibited cone responses immediately following exposure to
light, treated larvae had normal OKR responses after prolonged
light exposure. This agrees with previous genetic studies demon-
strating OKR contrast sensitivity is unaffected in Rpe65a knock-
down larvae raised under normal lighting conditions (20), but
implicatesRPE-specificRpe65a in immediatephotopicvisionafter
dark adaptation.However,we cannotunequivocally exclude a role
for zebrafish Rpe65c inMüller glia in the immediate response.
Retinoid profiles are altered in dark-adapted zebrafish larvae
treated with visual cycle isomerase inhibitors
Retinoid analysis from dark-adapted zebrafish larvae show
reduced 11-cis-retinoids (11cROL, 11cRAL, and 11cRP) with
emixustat treatment. Fenretinide also dose-dependently sup-
pressed immediate photopic vision. However, although 11-cis-
retinoid levels were lower in fenretinide-treated versus vehicle-
treated larvae, the degree of suppressed vision was less than
with emixustat. Levels of atROL, atRAL, and atRP were also
suppressed in fenretinide-treated versus vehicle-treated larvae,
an effect not observed in emixustat-treated larvae.
Exogenous 9cRAL supplementation restores immediate
photopic vision following visual cycle inhibition
Treatment with exogenous 9cRAL recovers ERG responses
in Rpe65/ mice and functional vision in Rpe65-deficient
dogs, establishing its potential as a chromophore replacement
therapy (30, 47, 48). In agreement, immediate photopic vision
significantly improved emixustat and/or fenretinide-treated
larvae supplemented with 9cRAL. Thus, the impaired cone
vision we observe is a specific pharmacological effect on the
visual cycle and not a result of ocular toxicity. Additionally,
fenretinide-treated larvae display impaired immediate pho-
topic vision despite relatively high 11cRAL levels. The improve-
ment of visionwith exogenous 9cRAL suggests that the 11cRAL
stores present may be unavailable to cones in fenretinide-
treated larvae. Improved vision in emixustat-treated larvae sup-
plemented with 9cRAL was not coupled to increased 11cRAL
levels. Instead, all 9-cis-retinoid profiles (9cRAL, 9cROL, and
9cRP) were significantly increased, indicating that the recov-
ered vision may be mediated by iso-opsins.
Differential requirements of Rpe65 for immediate and early
cone-based photopic vision
Because emixustat did not affect late photopic vision in
zebrafish, we investigated whether impaired immediate
photopic vision in dark-adapted animals could recover in a
light-dependent, Rpe65-independent manner. Pharmacologi-
cal RPE65 inhibition significantly reduces 11cRAL levels in
multiplemodels, e.g. by Ret-NH2 in zebrafish (20), by emixustat
in mice (26), and by emixustat or fenretinide in ex vivo RPE
microsomes (32). Here, as expected, dark-adapted, WT larvae
treated with emixustat display an 10-fold reduction in
11cRAL. Interestingly, 11cRAL levels did not recover following
30 min of light exposure despite recovery of early photopic
vision. A reduction in total retinoid was observed indicating
that emixustat may be trapping atRAL and forming unknown
or undetectable conjugates. Consistent with light overcoming
emixustat-mediated visual impairment, atRAL was restored to
levels similar to vehicle controls 30 min following light expo-
sure, consistent with initiation of phototransduction. However,
that photopic vision recovers in the light, surmounting emix-
ustat, without an associated increase in 11cRAL levels is
intriguing. Potentially, the small amount of 11cRAL available to
the photopic cycle activates cone opsins in a steady state and is
sufficient to sustain a stable visual response during this 30-min
light exposure. As retinyl esters support cone function (49) and
are a significant source for cone pigment regeneration (50), one
possibility is that 11cRP reserves were utilized upon exposure
to light. However, in line with previous studies employing
RPE65 inhibitors in zebrafish (49), emixustat treatment com-
pletely blocked generation of 11cRP both in the dark and light.
An alternative RPE65-independent isomerization event for
cone pigment regeneration was recently described inmice (18).
This cone regeneration mechanisms involves Müller glia-ex-
pressed RGR-opsin, which converts atROL to 11cROL upon
visible light exposure. In RPE cells, RGR opsin also affects light-
dependentmobilization of atREs, suggesting it diverts substrate
away from RPE65 in RPE cells toward the Müller cell visual
cycle (51).
Using genetic and pharmacological approaches, we investi-
gate the molecular mechanisms mediating this 30-min switch
from a light-independent visual cycle, supporting immediate
photopic vision, to a light-dependent visual cycle, supporting
early photopic vision. When WT larvae were treated with the
potent RBP4 antagonist A1120 alone, immediate photopic
vision was reduced, but recovery of early photopic vision was
equivalent to vehicle controls. This indicates that RBP4 is
required for the nonphotopic visual cycle but not for the pho-
topic visual cycle. Furthermore, knockout of degs1/ in
zebrafish showed no modulation of immediate, early, or late
photopic vision suggesting Des1 is not essential for either the
photopic or nonphotopic visual cycles. The phenotypic differ-
ences between Des1 pharmacological inhibition and the
genetic knockout model may be attributed to polypharmacol-
ogy or genetic compensation and illustrates the importance of
applying complementary approaches in parallel. Mammalian
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CRALBP forms a complex with DES1 (15) and is reported to
regulate the cone visual cycle. Deletion of CRALBP in mice
results in reduced photopic ERG responses (52). Adenovirus-
mediated delivery ofMüller cell CRALBP restored cone-driven
responses. Here, knockout of the RPE-expressed rlbp1b paral-
ogue in zebrafish did not eliminate immediate or early photopic
vision in larvae treated with emixustat. All studies reported
here employ standard OKR conditions (i.e. 1 cm stripes with
99% contrast) in 5 dpf larvae. Future investigations at older ages
or using more sophisticated contrast sensitivity or visual acuity
behavioral assays may unveil more subtle visual defects follow-
ing pharmacological or genetic perturbations.
Significantly, fenretinide and emixustat hydrochloride have
reached phases II and III clinical trials, respectively, for use in
geographic atrophy. Night blindness and dry eye are side effects
of fenretinide treatment (53). Our data demonstrate that fen-
retinide also impairs photopic vision; thus, concerns arise over
potential adverse drug reactions in the clinic with fenretinide
use to treat diseases such as geographic atrophy, cancer, acne,
cystic fibrosis, and psoriasis. Likewise, emixustat is now in
phase III clinical trial for the inherited retinal degeneration
Stargardt disease with the intention of suppressing retinoid
cycling (37).We show that the photopic visual cycle overcomes
emixustat, which may have significant impact on clinical
outcomes.
In summary, pharmacological and genetic models of visual
cycle modulation enhanced our knowledge of the fundamental
mechanisms of cone photopic vision. Differential stages of ver-
tebrate photopic vision demand differential biochemical path-
ways, in light and dark. Rpe65 regenerates photopigment
required by cones for immediate photopic response. In con-
trast, during sustained light, Rpe65 appears redundant to a
light-dependent regeneration of visual pigments, a process
whereby diminished 11cRAL levels are sufficient for photopic
vision.
Experimental procedures
Zebrafish breeding and maintenance
Adult zebrafish were maintained in a 14-hour light, 10-hour
dark cycle in a recirculatingwater system at 28 °C. Annual facil-
ity environmental parameters are published online (54).
WT (Tübingen) larvae were generated through natural
spawning. Larvae were raised at 28 °C in embryo medium
(0.137 M NaCl, 5.4 mM KCl, 5.5 mM Na2HPO4, 0.44 mM
KH2PO4, 1.3 mM CaCl2, 1.0 mMMgSO4, and 4.2 mMNaHCO3)
containing methylene blue (Sigma-Aldrich, UK).
Ethics statement
All experiments with zebrafish larvae were performed
according to ethical exemptions granted by the UCD Animal
Research Ethics Committee, University CollegeDublin (AREC-
Kennedy), and the Health Products Regulatory Authority (Pro-
ject Authorization AE18982/P062).
Generation of mutant zebrafish
Custom crRNA guides, containing an NGG protospacer
adjacent motif (PAM) were designed per gene using Benchling
(RRID:SCR_013955) CRISPR guide software. All guide se-
quences and PAMs are listed in Table S1. The Alt-R system
(Integrated DNA Technologies) was used to knock out rlbp1b
and degs1 in zebrafish. Briefly, 36 ng/l crRNA and 67 ng/l
tracrRNA were complexed in nuclease-free duplex buffer by
heating to 95 °C for 10 min. Sample was cooled to room tem-
perature, and a final working concentration of 0.5 g/l Strep-
tococcus pyogenes Cas9 nuclease (Integrated DNA Technolo-
gies) was added. The mixture was heated to 37 °C for 15 min
before microinjection into WT embryos at one-cell stage.
Injected fish were raised until adulthood and outcrossed to
screen for germline transmission of the null target gene. Iso-
genic F1 heterozygous adult fish were incrossed to generate
homozygous F2 mutants.
Genomic DNA extraction and PCR
DNA was extracted from injected F0 or germline F2
rlbp1b/ larvae by boiling the sample at 95 °C in NaOH (50
mM) (Sigma-Aldrich, UK) before neutralizing with 1/10th
Trizma (Tris base) (Sigma-Aldrich, UK). The region of interest
was amplified by PCR using the following primers, which span














. Fragment sizes were run on a
1.5% agarose gel and compared against a 100-bp DNA ladder
(New England Biolabs, UK).
Total RNA extraction, cDNA synthesis, and RT-PCR/qPCR
At 5 dpf, 20–50 eyes (10–25 larvae) were enucleated and
stored inRNAlater (Qiagen,Germany) individually at 4 °C. Lar-
val trunks were genotyped as described previously. Eyes were
pooled, and total RNAwas extracted usingmirVanaTMmiRNA
isolation kit (Thermo Fisher Scientific) as per the manufactu-
rer’s instructions.NaOAc (3M) and 100%ethanolwere added to
the eluted RNA, vortexed, and left overnight at 20 °C. Sam-
ples were centrifuged at 14,000 rpm for 60 min at 4 °C; the
supernatant was removed before the pellet was resuspended in
80% ethanol and centrifuged for a further 60min at 14,000 rpm.
Supernatant was discarded, and the pellet was resuspended in
ultrapure water. Total RNA concentration was quantified at
260 nm (Spectrophotometer ND-1000), and samples were
stored at80 °C until further use. cDNAwas synthesized using
PrimeScriptTM RT reagent kit (Perfect Real Time) (TAKARA,
Japan). qRT-PCRs were made up on ice with 0.2 l of forward






5 l of SYBR GreenMaster Mix (Thermo Fisher Scientific), 3.6
l of RNase-free water, and 1 l of cDNA template (12.5 ng)
were added per sample. qRT-PCR cycles were carried out using
the following parameters: 50 °C for 2min, 95 °C for 10min, and
95 °C for 15 s with 40 repeats and 60 °C for 1 min on a Quant
Studio 7 Flex Real-Time PCR system. To evaluate degs1 expres-
sion, the cDNA was amplified by RT-PCR using the following
primer sets: degs1 forward 2, 5
-GTCAGCACGATGGTGGT-
GTC-3
, and degs1 reverse 2, 5
-TGGAGACCCATGCCCAG-
CAT-3
; degs1 forward 3, 5
-GGACGTGGACATCCCCAC-
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TGA-3
, and degs1 reverse 3, 5
-AGCTGGATGGCCACGT-
TCAG-3
. Samples were run on a 1.5% agarose gel and com-
pared against a 100-bpDNA ladder (NewEnglandBiolabs,UK).
Drug preparation and treatment
WT, Rlbp1b, and Des1 larvae were raised from embryos
under standard 14-h light and 10-h dark conditions. At 3 dpf,
five larvae per well were placed in 48-well cell culture plates
(Greiner Bio-one, Austria). Emixustat hydrochloride (Med-
chem), fenretinide (Cayman Chemical), and A1120 (Sigma-Al-
drich, UK) were prepared in embryo medium, and 400 l of
drug solution at 1–50M in 0.01–0.5%DMSOwas added to the
wells. For emixustat and fenretinide combinations, 1–10 M
fenretinide was added 15 min prior to the addition of 50 M
emixustat. Larvae were initially treated at 74–76 hpf, and the
drugwas replaced at 98–100 hpf. Four hours following primary
drug treatment (i.e. 78–80 and 102–104 hpf), 10 M 9-cis-ret-
inal (Sigma-Aldrich, UK) was added to the embryo medium.
Exogenous 9-cis-retinal was handled under dim red light.
Visual behavior analysis
To measure OKR, single larvae were immobilized in pre-
warmed 9%methylcellulose (Sigma-Aldrich, UK) and placed in
the center of a rotating drum containing 20 vertical, 1 cm thick
black and white stripes. The angle subtended was 0.58 rad
(33.7°). The drum was rotated at 18 rpm for 30 s in a clockwise
direction and 30 s in a counterclockwise direction. Saccadic eye
movements per min were recorded manually. All OKR mea-
surements were performed in larvae at 5 dpf between 10 a.m.
(ZT 2.5) and 2 p.m. (ZT 6.5).
Histological analysis
Larvae were fixed in glass vials containing 2.5% glutaralde-
hyde, 2% paraformaldehyde, and 0.1% Sorenson’s phosphate
buffer (pH 7.3) and were placed at 4 °C. Samples were washed
before post-fixation in 1% osmium tetroxide (Sigma-Aldrich,
UK) and dehydrated using an ethanol gradient (30, 50, 70, 90,
and 100%). Samples were transferred to propylene oxide
(Sigma-Aldrich, UK) and embedded in agar epoxy resin over-
night, and 0.5-m sections were cut using an ultramicrotome
(Leica EM UC6). Sections were placed on glass slides and
stained with toluidine blue (Sigma-Aldrich, UK) for 30–60 s
and imaged using a Leica DMLB bright-field illumination
microscope with a Leica DFC 480 camera attachment.
For transmission EM, 0.08-m sections were cut using a dia-
mond knife and a Leica EM UC6 ultramicrotome. Sections
were transferred to a support grid, stained with uranyl acetate
and lead citrate, and imaged on a FEI-Tecnai 12 BioTwin trans-
mission electron microscope (FEI Electron Optics).
Drug-treated larvae were fixed at 5 dpf with 4% paraformal-
dehyde (Sigma-Aldrich, UK). Larvae were cryoprotected in a
sucrose series before embedding in optimal cutting tempera-
ture (OCT)medium (VWR International). Sections were cut to
14 m and thaw-mounted onto charged Superfrost plus slides
(Thermo Fisher Scientific). Sections were rehydrated using 1	
PBS supplemented with Tween 20 (Sigma-Aldrich, UK) (0.01%
PBST) before blocking in 10% goat serum (Sigma-Aldrich, UK)
for 1 h. Monoclonal zpr-1 was used at 1:200 (Zebrafish Inter-
national Resource Center, Eugene, OR). Slides were washed
before incubating with the secondary antibody (Alexa Fluor
488 anti-mouse IgG). Primary and secondary antibodies
were diluted in blocking solution. Slides were mounted using
Vectashield (Vector Laboratories) before imaging using a
Zeiss LSM510 confocal microscope (Carl Zeiss AG, Germany)
with a	63 objective.
Retinoid quantification
For retinoid analysis, 105 larvae per treatment condition at 5
dpf were euthanized in ice water before their heads were col-
lected under dim red light. For normal-phase HPLC analysis of
retinoids, all retinoid extractions were carried out under dim
red light in a dark room. Zebrafish headswere stored at80 °C,
thawed on ice, and homogenized in 500 l of phosphate-buff-
ered saline (PBS) using a glass tissue grinder (Kontes). Protein
concentration was determined using 50 l of sample and a
Micro BCA protein assay kit (Pierce). To the remaining 450 l
of homogenate, 25 l of 5% SDS (0.2% SDS final concentra-
tion) and 50 l of brine were added, and samples were briefly
mixed. Hydroxylamine hydrochloride (500 l of 1.0 M solution
in pH 7.0 PBS) was added to generate retinal oxime, and sam-
ples were vortexed and incubated at room temperature for 15
min. The aqueous phase was quenched and diluted using 2 ml
of coldmethanol. The sampleswere twice extracted by addition
of 2-ml aliquots of hexane, brief vortexing, and centrifugation
at 3000 	 g for 5 min to separate the phases. Pooled hexane
extracts were added to 13	 100-mmborosilicate test tubes and
evaporated to dryness under a stream of nitrogen. Dried sam-
pleswere dissolved in 100l of hexane and analyzed by normal-
phase HPLC using an Agilent 1100 series chromatograph
equippedwith a Supelcosil LC-Si column (4.6	 250mm, 5m)
using a 0.2–10% dioxane gradient in hexane at a flow rate of 2
ml per min. The elutedmobile phase was analyzed using a pho-
todiode-array detector. Spectra (210–450 nm) were acquired
for all eluted peaks. The identity of eluted peaks was established
by comparison with spectra and elution times of known
authentic retinoid standards. Retinoid amounts were quanti-
tated by comparing their respective peak areas to calibration
curves established with retinoid standards.
Photostability of emixustat hydrochloride
Liquid chromatography used a Dionex Ultimate 3000 RSLC
micro-LC system (Thermo Fisher Scientific). Separation was
performed using a Thermo Acclaim RSLC 120 2.2-m, 120 Å,
1.0 	 100-mm LC column (Thermo Fisher Scientific). LC
parameters were as follows: elution mode, gradient (from 90%
A to 90% B in 15 min); flow rate, 45 l/min; column tempera-
ture, 3 °C; detectorwavelength, 230nm; and injection volume, 2
l. Mobile phases were as follows: A, H2O  0.1% formic acid
(v/v); B, acetonitrile 0.1% FA (v/v). Mass spectrometry anal-
ysis was performed using an LTQ-XL–Orbital-XL (Thermo
Fisher Scientific) equipped with HESI II ESI ion source. Source
parameters were as follows: ion spray voltage (V), 4.6; capillary
temperature (°C), 280; sheath gas, flow gas flow (Arb), 20; and
auxiliary gas flow (Arb), 8. Resolution was set to 30,000 in FT
mode, andmass range set to 150–500 Da in positive-ionmode.
Peak area of emixustat-protonated mass was calculated and
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recorded using Xcalibur software (version 2.21). The proto-
nated mass ions were identified using an error tolerance of 5
ppm for their corresponding theoretical monoisotopic mass.
For nuclear magnetic resonance (NMR) analysis, emixustat
(7 mg) was dissolved in DMSO-d6 (600 l) under dim red light
and covered with aluminum foil until 1H NMR and HSQC
experiments were performed. The NMR tube was exposed to
visible light for 30 min, followed by a repeat NMR analysis. 1H
NMR spectra weremeasured in DMSO-d6 at 400MHz. Chem-
ical shifts () are quoted in parts per million (ppm) referenced
to residual solvent peak (e.g. DMSO-d6: 1H, 2.50 and 3.33 ppm).
Statistical analysis
Statistical analysis was performed using GraphPad PrismTM
software (GraphPad, San Diego, CA). A two-tailed Student’s
unpaired t test was applied comparing two experimental
groups. For analysis involving more than two independent
groups, a one-way ANOVA and Dunnett’s multiple compari-
son test or Bonferroni post hoc test were performed. Experi-
ments composed of two variables were tested for significance
using a two-way ANOVA and a Bonferroni post hoc test. All
data are presented as mean  S.D. Statistical significance was
assigned to the following p values: * p 0.05, ** p 0.01,
and *** p 0.001.
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